Enovis (ENOV) Net Equity Issued and Repurchased (2011 - 2026)
Enovis' (ENOV) quarterly Net Equity Issued and Repurchased came in at $628000.0 in Q2 2026, up 84.16% year-on-year from $341000.0 in Q2 2025, and up 232.28% on a QoQ basis from $189000.0 in Q4 2025.
Enovis (ENOV) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends
Enovis (ENOV) has 16 years of Net Equity Issued and Repurchased data on file, last reported at $628000.0 in Q2 2026.
- On a quarterly basis, Net Equity Issued and Repurchased rose 84.16% year-over-year to $628000.0 in Q2 2026; TTM through Apr 2026 was $1.6 million, a 19.42% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, down 29.67% from the prior year.
- Net Equity Issued and Repurchased for Q2 2026 stood at $628000.0, up from $189000.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for ENOV reached as high as $3.3 million in Q4 2022 and fell as low as $104000.0 in Q3 2023.
- Historically, Net Equity Issued and Repurchased has averaged $713125.0 across 5 years, with a median of $483000.0 in 2022.
- Across the five-year window, Net Equity Issued and Repurchased sank 99.83% in 2022 and surged 263.46% in 2024, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $3.3 million in 2022, then sank by 91.26% to $287000.0 in 2023, then rose by 11.15% to $319000.0 in 2024, then sank by 40.75% to $189000.0 in 2025, then soared by 232.28% to $628000.0 in 2026.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $628000.0 in Q2 2026, $189000.0 in Q4 2025, and $788000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 628,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 628,000.00 |
| Apr 3, 2026 | 628,000.00 |
| Oct 3, 2025 | 189,000.00 |
| Oct 3, 2025 | 189,000.00 |
| Jul 4, 2025 | 788,000.00 |
| Jul 4, 2025 | 788,000.00 |
| Apr 4, 2025 | 341,000.00 |
| Apr 4, 2025 | 341,000.00 |
| Dec 31, 2024 | 319,000.00 |
| Dec 31, 2024 | 319,000.00 |
| Sep 27, 2024 | 378,000.00 |
| Sep 27, 2024 | 378,000.00 |
| Jun 28, 2024 | 306,000.00 |
| Jun 28, 2024 | 306,000.00 |
| Mar 29, 2024 | 871,000.00 |
| Mar 29, 2024 | 871,000.00 |
| Dec 31, 2023 | 287,000.00 |
| Dec 31, 2023 | 287,000.00 |
| Sep 29, 2023 | 104,000.00 |
| Sep 29, 2023 | 104,000.00 |